Saúde Pública/Medicina Humanitária
Telessaúde pediátrica na era da pandemia de COVID-9 e além.
7 Jul, 2021 | 08:08hPediatric Telehealth in the COVID-19 Pandemic Era and Beyond – Pediatrics
Diretriz RCOG | Vacinação contra o coronavírus (COVID-19) na gestação.
7 Jul, 2021 | 08:08hCoronavirus (COVID-19) Vaccination in Pregnancy – Royal College of Obstetricians & Gynaecologists
Ver também: Resources and FAQs – Royal College of Obstetricians & Gynaecologists
Comentário no Twitter
We have published an interim update to the main coronavirus and pregnancy guidance to summarise the guidance on COVID-19 vaccination and pregnancy. Find out more: https://t.co/2YDyZFrVWJ pic.twitter.com/KnwXDvZls2
— RoyalCollegeObsGyn (@RCObsGyn) July 1, 2021
Novas recomendações da OMS para rastreamento preventivo do câncer de colo de útero – A nova diretriz recomenda um teste baseado em HPV-DNA a cada 5 anos como método de escolha, em detrimento à inspeção visual com ácido acético (visual inspection with acetic acid – VIA) ou citologia (Papanicolaou).
7 Jul, 2021 | 08:06hComunicado de imprensa: New recommendations for screening and treatment to prevent cervical cancer – World Health Organization
Comentário no Twitter (fio – clique para saber mais)
🆕 recommendations for screening and treatment to prevent #CervicalCancer will help countries take the next step towards elimination. Cervical #cancer is the 4th most common cancer among women worldwide 🌎🌍🌏
👉 https://t.co/2vfxqa9FMB pic.twitter.com/zC0h20nAce
— World Health Organization (WHO) (@WHO) July 6, 2021
OMS promete um compromisso ainda maior em relação à saúde e ao empoderamento femininos.
7 Jul, 2021 | 08:05hWHO pledges extensive commitments towards women’s empowerment and health – World Health Organization
Comentário no Twitter (fio – clique para saber mais)
WHO pledges extensive commitments towards women’s empowerment & health with focus on:
✅ ending gender-based violence
✅ advancing sexual & reproductive health & rights
✅ supporting health workers, as well as feminist movements & leadershiphttps://t.co/52pdTaWPTY #ActForEqual— World Health Organization (WHO) (@WHO) July 5, 2021
Estudo randomizado | Para médicos com alto volume de prescrição de antibióticos na atenção primária, um feedback informativo levou a significativas reduções no total dessas prescrições e na duração prolongada delas, assim como no custo dos medicamentos.
7 Jul, 2021 | 08:02hEffect of Antibiotic-Prescribing Feedback to High-Volume Primary Care Physicians on Number of Antibiotic Prescriptions: A Randomized Clinical Trial – JAMA Internal Medicine (gratuito por tempo limitado)
Comentário: Studies highlight impact of clinician feedback on antibiotic prescribing – CIDRAP
Comentário no Twitter (fio – clique para saber mais)
We conducted a randomized controlled trial of providing antibiotic prescribing feedback to high volume primary care physicians in Ontario, 🇨🇦 https://t.co/zmF2tvJ5n5
— Kevin Schwartz (@DrKevinSchwartz) July 6, 2021
Choosing Wisely para COVID-19: 10 recomendações baseadas em evidências para pacientes e médicos.
6 Jul, 2021 | 11:26hOpinião | Fracionamento das doses de vacina contra COVID-19 poderia ampliar o uso de suprimentos limitados e reduzir a mortalidade.
6 Jul, 2021 | 11:25h
Comentário no Twitter
For accelerating global containment, the use of lower doses of vaccines, w/ potential for =/high efficacy, should be considered, by @bencowling88 @sarahcobey @NatureMedicine https://t.co/H4YtnJEsdR
Also applies to @moderna_tx https://t.co/K0yJMirXFhhttps://t.co/8k7PGOp43s pic.twitter.com/ptCA1VtKzD— Eric Topol (@EricTopol) July 5, 2021
Estudo randomizado | Ivermectina não evita hospitalização em pacientes com COVID-19.
6 Jul, 2021 | 11:24hComentário: Ivermectin: balance of evidence shows no significant benefit against Covid-19 – MSN News
Relacionado: Ivermectin for the treatment of COVID-19: A systematic review and meta-analysis of randomized controlled trials – “IVM did not reduce all-cause mortality, length of stay or viral clearance in RCTs in COVID-19 patients with mostly mild disease”. E Ivermectin is the new hydroxychloroquine, take 2 – “Ivermectin shouldn’t be used to treat COVID-19 outside of the context of a well-designed clinical trial”. E Therapeutics and COVID-19 | WHO guideline update advises Ivermectin should only be used to treat COVID-19 within clinical trials E RCT: Ivermectin does not improve time to resolution of symptoms among adults with mild COVID-19
Editorial | Não fique aí sentado, faça alguma coisa… mas não cause dano: os aspectos preocupantes das intervenções experimentais contra a COVID-19.
6 Jul, 2021 | 11:23h
Comentário no Twitter
Shortcutting science perpetuates ineffective/unsafe treatments: with #COVID19 plethora of interventions (most next-to-no basis/inconsistent effects) trialled or given on compassionate grounds regardless risks. Will mistakes be acknowledged & lessons learnt?https://t.co/p53WyeMLEC pic.twitter.com/zUwlML8Pft
— Intens Care Med (@yourICM) July 5, 2021
Perspectiva | Aprendendo com a crise: a construção de sistemas resilientes para combater futuras pandemias.
6 Jul, 2021 | 11:22hLearning from crisis: building resilient systems to combat future pandemics – The Lancet